Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

INOVIQ Engages ResearchDX to Develop & Validate SubB2M-Tests (ASX:IIQ)

* INOVIQ’s SubB2M technology detects the pan-cancer biomarker Neu5Gc found at elevated levels in multiple human cancers * SubB2M-based tests are in early development for multiple uses includi...read more

INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test (ASX:IIQ)

* INOVIQ and The University of Queensland (UQ) expand collaboration to develop a world-first exosome-based ovarian cancer screening test * UQ to develop exosome-based blood test for the earlier det...read more

INOVIQ - Update on Legal Proceedings and BARD1 Autoantibody Program (ASX:IIQ)

INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company) refers to its previous announcement to the ASX on 24 February 2021 in relation to the legal proceedings commenced in the Supreme Court of Victoria ag...read more

INOVIQ - Appendix 4D and Half Year Financial Report (ASX:IIQ)

To view the appendix, download the attached PDF.

INOVIQ - Brazilian Patent Issued for Lung & Colorectal Cancer (ASX:IIQ)

-- Brazilian patent granted covering use of BARD1 isoforms in lung and colorectal cancer -- Protects a BARD1 autoantibody test for detection of lung or colorectal cancer Melbourne, Austral...read more

INOVIQ - Appendix 4C & Quarterly Activities Report (ASX:IIQ)

-- Positive EXO-NET RUO evaluations concluded with key Australian research institutions and further collaboration expected -- Two patents granted in the US and China protecting a potential BARD1 au...read more

BARD1 Life Sciences Changes its Name to INOVIQ (ASX:IIQ)

Change of company name to INOVIQ Ltd New code ASX:IIQ from 9 December 2021 INOVIQ represents ‘intelligent innovation’ as the Company builds an innovative portfolio of diagnostic and...read more

BARD1 Life Sciences - Cleansing Notice - Issued of Four Shares - Resolution 5 AGM (ASX:IIQ)

BARD1 Life Sciences Limited, (ASX:BD1) ("BARD1" or "the Company") today announced the quotation of four fully paid ordinary shares (Shares) via an Appendix 2A – Application...read more

BARD1 Life Sciences - Application for quotation of securities (ASX:IIQ)

To view the Application for quotation of +securities, download the attached PDF.

BARD1 Life Sciences - Application for quotation of securities (ASX:IIQ)

To view the Application for quotation of +securities, download the attached PDF.

BARD1 Life sciences - Results of 2021 Annual General Meeting (ASX:IIQ)

BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company) held the 2021 Annual General Meeting (AGM) yesterday, 29 November 2021, at 2.00pm (ADST). Voting for all resolutions tabled at the AGM...read more

BARD1 Holdings - AGM Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

BARD1 Life Sciences - New BARD1 Exosome Liquid Biopsy Project (ASX:IIQ)

Commercial Research Agreement signed with the Mucosal Immunology Research Group (MIRG) at Griffith University Aims to develop exosome-based RNA test for earlier detection of breast and ovarian ca...read more

BARD1 Life Sciences - Application for quotation of securities (ASX:IIQ)

To view the Application for quotation of +securities, download the attached PDF.

BARD1 Life Sciences - Notification regarding unquoted securities - BD1 (ASX:IIQ)

To view the Notification of Issue, Conversion or Payment up of Unquoted Equity Securities, download the attached PDF.

Viewing: 61 - 75 of 111 Previous | Next